Immune boosters, supplements and immunotherapy — what helps, what harms, what to disclose

No. No supplement has been shown in cancer trials to make immunotherapy work better. No guideline body — NCCN, ASCO or ESMO — recommends one for that purpose. Immunotherapy does not need the immune system to be made generally stronger. It works by releasing one specific brake that a tumour uses to hide from immune cells.

The confusion is understandable, and the word itself causes most of it. "Immunotherapy" sounds like something that boosts immunity, so an "immunity booster" sounds like a natural partner for it. That is not how the treatment works. Checkpoint inhibitor immunotherapy — described here at class level only, because the specific medicine and schedule are always your oncologist's decision — does not add strength to the immune system. It removes a signal that tumour cells use to switch immune cells off.

Because it releases a brake rather than presses an accelerator, a product that promises to "boost immunity" is not adding to the effect. What it can do is make the picture harder to read. Every decision on immunotherapy — continue, pause, treat a side effect, change the plan — is made from your symptoms and your blood tests. Anything that quietly changes either one makes those decisions less accurate.

Some things are genuinely supported: eating enough, especially protein, keeping up gentle daily activity, and sleeping properly. Food-first nutrition guided by an oncology dietitian is part of standard care at CION and carries none of the risks described on this page.

A supplement prescribed for a documented deficiency — vitamin D or iron confirmed on a blood test, for example — is a different thing altogether. That is a medical decision your team makes with a result in front of them, not an over-the-counter immunity booster.

1. 1

   Write the list before you decide anything

   Every tablet, capsule, powder, syrup, sachet, kashayam and drink, with the dose and how long it has been taken. Photographs of the labels are enough. Do not filter the list first — the item that seems too harmless to mention is often the one that matters.

2. 2

   Hand it to the treating team, not to a search engine

   The same list goes to the medical oncologist, the day-care nursing team and the dietitian, so it sits in the file before the next cycle. A tumour board can only account for what it has been told about.

3. 3

   Start nothing new in the week before an infusion or a scan

   This is the single most useful rule on this page. A product introduced in that window makes any change afterwards impossible to attribute — nobody can separate the cancer, the immunotherapy and the new bottle. Wait, ask, then start if the team agrees.

4. 4

   Pause, don't hide

   When the team asks for a pause it is almost always for the treatment period only, not forever. Hiding a product is the one choice with no upside: if a side effect appears later, the team investigates blind, and the investigation is slower and more invasive than the conversation would have been.

5. 5

   Re-check at every scan and every change of plan

   A supplement that was acceptable alongside immunotherapy on its own may not be acceptable once another drug joins the plan. This matters most when a second agent is added — see immunotherapy with targeted therapy, where tablet-based medicines and liver metabolism are directly involved, and dual immunotherapy, where side effects are more frequent and attribution matters even more.

No. Ayurveda, homeopathy and household remedies are a trusted part of everyday health for many families across Telangana and Andhra Pradesh, and wanting to do something for a person you love is not misinformation. The concern on this page is far narrower than the tradition itself.

It is about concentrated, unregulated, high-dose products taken during a treatment whose side effects are judged entirely by blood tests and symptoms. A daily household preparation and a bought "immunity" package sold on a promise are not the same thing, and your oncology team will tell you which is which if you ask. The goal is disclosure, so interactions can be checked — not conversion, and not giving up a practice that brings comfort.

If you are the family member who brought the product home, one thing is worth saying plainly: you have not done something wrong by buying it, and nobody at the clinic will treat you as though you have. Bring it in. The conversation takes five minutes and it protects the person you were trying to help.

Every sequencing decision on this page — start, pause, stop, resume — belongs with the treating oncology team, who can see the scans, the blood work and the full plan. Nothing here replaces that consultation.

• Dual Immunotherapy: Two Immune Agents Together — when two immune agents are used at once, side effects are more frequent, so a clean supplement list matters even more.
• Immunotherapy With Radiation: Does One Help the Other? — the sequencing question asked properly, with real evidence rather than a promise.
• Immunotherapy With Targeted Therapy: When They Are Combined — the combination where herbal preparations and liver metabolism have the clearest potential to interfere.
• Immunotherapy at CION Cancer Clinics — how immunotherapy is assessed, given as day care, and monitored across CION centres.

This page is general information and does not replace a consultation. Always tell your oncology team about any supplement, herbal preparation or "immunity" product before starting, pausing or stopping it.

Almost every family asks us this exact question

Someone always recommends a powder, a kashayam or a drip. Asking whether it is safe alongside immunotherapy is the responsible thing to do, not an awkward one. Ask us directly — plain language, no cost, no judgement.